| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c43d3df20da48e2043414a0db45c0d18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fafa621419e361b96d97ca831eb8ee7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bc519d97d37dc89492a53754185e338
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f11306bcfd405fb8cd5e01d48d688bfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b10090f44cd606c10281473df639867b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae17441b985204ae10c2cc83e8fe1240 |
| publicationDate |
2003-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20030085841-A |
| titleOfInvention |
A therapeutic agent for treating estrogen deficiency syndrome |
| abstract |
The present invention relates to a new pharmaceutical use of ginsenoside Rb1, and more particularly, to a drug for treating estrogen deficiency syndrome comprising ginsenoside Rb1 or a pharmaceutically acceptable salt as an active ingredient. It is about. |
| priorityDate |
2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |